FDA Drug Application (203411) for NEVIRAPINE by SANDOZ INC

Back to FDA Applications sponsored by SANDOZ INC

Application Number203411
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage400MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNEVIRAPINE
Active IngredientNEVIRAPINE

Active IngredientCount
List of drugs with Active Ingredient NEVIRAPINE17


Back to FDA Applications sponsored by SANDOZ INC